GlassScriptPhysician profile
Ricardo Perez
NPI 1124095757
$5,340.33
in general payments reported to CMS, 2019-2025
17 companies · $1,605 in 2025
The $1,605 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $169 · 2021: $855 · 2022: $915 · 2023: $751 · 2024: $1,046 · 2025: $1,605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,401.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,842.20 | 2020-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $1,389.11 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $448.05 | 2020-2025 | Jardiance |
| Lilly USA, LLC | $302.20 | 2020-2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $252.99 | 2025 | Freestyle Libre 3 |
| Medtronic, INC. | $241.72 | 2022 | |
| Madrigal Pharmaceuticals | $143.57 | 2025 | Rezdiffra |
| Glaxosmithkline, LLC. | $142.86 | 2022-2024 | Arexvy |
| Exact Sciences Corporation | $139.86 | 2024-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $126.63 | 2022-2024 | |
| Abbvie INC. | $110.78 | 2025 | |
| Amgen INC. | $109.04 | 2023-2025 | Otezla, Repatha, Repatha |
| Pfizer INC. | $23.19 | 2024 | |
| Qiagen, LLC | $20.78 | 2020 | |
| Phadia US INC. | $19.58 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $14.17 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.